Label: MYRRH WOMAN- menthol pill

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated April 26, 2018

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    menthol

  • INACTIVE INGREDIENT

    sodium sulfate, niacinamide, olive leaf, adenosine, etc

  • PURPOSE

    Cold odor Trichomonas candida infection treatment

    Lack of come secretion

    Vaginal cold urinary incontinence

    Insensitivity to orgasms

    Dry, rub and scar of Y zone

    Lack of vaginal elasticity

    Menopausal hormone imbalance

    Lack of libido

  • WARNINGS

    1. If the following symptoms occur after product use, stop using the product immediately and consult a dermatologist (continuous use can exacerbate the symptoms).
    1) Occurrence of red spots, swelling, itchiness, and other irritation
    2) If the symptoms above occur after the application area is exposed to direct sunlight

    2. Do not use on open wounds, eczema, and other irritations
    3. Precaution for Storage and Handling
    1) Close the lid after use
    2) Keep out of reach of infants and children
    3) Do not to store in a place with high/low temperature and exposed to direct sunlight

    4. Use as avoiding eye areas.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.

  • INDICATIONS & USAGE

    Wash the Y zone thoroughly, then put the Woman Essence in a pill and put it deeply into the vagina
    After 7 days, it is steadily used for 2 ~ 3 days for 4 months.

  • DOSAGE & ADMINISTRATION

    for vaginal use only

  • PRINCIPAL DISPLAY PANEL

    label

  • INGREDIENTS AND APPEARANCE
    MYRRH WOMAN 
    menthol pill
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72263-0002
    Route of AdministrationVAGINAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MENTHOL (UNII: L7T10EIP3A) (MENTHOL - UNII:L7T10EIP3A) MENTHOL0.5 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    ADENOSINE (UNII: K72T3FS567)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    Product Characteristics
    ColorgrayScoreno score
    ShapeROUNDSize10mm
    FlavorMENTHOLImprint Code none
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72263-0002-14 g in 1 BOTTLE; Type 0: Not a Combination Product04/27/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other04/27/2018
    Labeler - MIR BIOTECHNOLOGY (694203851)
    Registrant - MIR BIOTECHNOLOGY (694203851)
    Establishment
    NameAddressID/FEIBusiness Operations
    MIR BIOTECHNOLOGY694203851manufacture(72263-0002)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!